134 related articles for article (PubMed ID: 3457551)
1. [Effect of cancer chemotherapeutic agents on induction of differentiation of cells and their therapeutic implications].
Hozumi M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):714-20. PubMed ID: 3457551
[TBL] [Abstract][Full Text] [Related]
2. [Experimental model for differentiation therapy of leukemia].
Hayashi M
Gan To Kagaku Ryoho; 1993 Jun; 20(8):1009-15. PubMed ID: 8099785
[TBL] [Abstract][Full Text] [Related]
3. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1605-11. PubMed ID: 6591856
[TBL] [Abstract][Full Text] [Related]
4. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
5. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy.
Hassan HT
Leuk Res; 2004 Jul; 28(7):667-71. PubMed ID: 15158086
[TBL] [Abstract][Full Text] [Related]
6. Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process.
Gallagher AP; Burnett AK; Bowen DT; Darley RL
Cancer Res; 1998 May; 58(9):2029-35. PubMed ID: 9581849
[TBL] [Abstract][Full Text] [Related]
7. [Acute myeloid leukemia].
Miyazaki Y; Kuriyama K
Gan To Kagaku Ryoho; 2001 Sep; 28(9):1192-8. PubMed ID: 11579629
[TBL] [Abstract][Full Text] [Related]
8. [Induction of the differentiation of tumor cells as an approach to tumor therapy].
Hozumi M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1349-57. PubMed ID: 2439010
[TBL] [Abstract][Full Text] [Related]
9. 1,25-Dihydroxycholecalciferol-induced differentiation of myelomonocytic leukemic cells unresponsive to colony stimulating factors and phorbol esters.
Bettens F; Schlick E; Farrar W; Ruscetti F
J Cell Physiol; 1986 Dec; 129(3):295-302. PubMed ID: 3491083
[TBL] [Abstract][Full Text] [Related]
10. [Sensitivity and differentiation induction effect of a human megakaryoblastic leukemia cell line (MEG-01s) by chemotherapeutic agents].
Okumura M; Ogura M
Rinsho Ketsueki; 1988 Aug; 29(8):1186-93. PubMed ID: 3204669
[No Abstract] [Full Text] [Related]
11. Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.
Honma Y; Kasukabe T; Hozumi M; Tsushima S; Nomura H
Cancer Res; 1981 Aug; 41(8):3211-6. PubMed ID: 6941852
[TBL] [Abstract][Full Text] [Related]
12. Fundamentals of chemo-differentiation therapy of myeloid leukemia.
Hozumi M
Anticancer Res; 1994; 14(3A):1177-92. PubMed ID: 8074470
[TBL] [Abstract][Full Text] [Related]
13. Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid.
Drach J; Lopez-Berestein G; McQueen T; Andreeff M; Mehta K
Cancer Res; 1993 May; 53(9):2100-4. PubMed ID: 8481912
[TBL] [Abstract][Full Text] [Related]
14. Control of differentiation and apoptosis of human myeloid leukemia cells by cytokinins and cytokinin nucleosides, plant redifferentiation-inducing hormones.
Ishii Y; Hori Y; Sakai S; Honma Y
Cell Growth Differ; 2002 Jan; 13(1):19-26. PubMed ID: 11801528
[TBL] [Abstract][Full Text] [Related]
15. Induction of differentiation and growth suppression of myeloid leukemia cells by sera of patients with hematological disorders.
Kanatani Y; Honma Y; Tsuchimochi T; Okabe-Kado J; Nagata N; Motoyoshi K; Hozumi M
Anticancer Res; 1993; 13(5C):1905-11. PubMed ID: 8267399
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
17. Differentiation induction therapy of acute myelogenous leukaemias.
Hassan HT
Haematologia (Budap); 1988; 21(3):141-50. PubMed ID: 3053358
[TBL] [Abstract][Full Text] [Related]
18. A fraction isolated from Ehrlich ascites carcinoma as an antitumor and differentiating agent against human leukemic cell ML-2.
Sur P; Nandi N; Ghosh P; Ghosh NC
Neoplasma; 2000; 47(2):114-7. PubMed ID: 10985477
[TBL] [Abstract][Full Text] [Related]
19. Induction of normal cell differentiation in leukemia as an approach to cancer therapy.
Sachs L
Prog Clin Biol Res; 1983; 132C():91-8. PubMed ID: 6579567
[No Abstract] [Full Text] [Related]
20. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
